Page last updated: 2024-11-05

trimebutine and Short Bowel Syndrome

trimebutine has been researched along with Short Bowel Syndrome in 1 studies

Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.

Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.

Research Excerpts

ExcerptRelevanceReference
"Effects of trimebutine maleate (TM) on intestinal motility in short bowel syndrome (SBS) were studied in conscious canines in both acute and chronic phases following 80% massive distal small bowel resection (MSBR)."3.70Effects of trimebutine on intestinal motility after massive small bowel resection. ( Homma, S; Iinuma, Y; Iwafuchi, M; Kanada, S; Ohtaki, M; Uchiyama, M; Yagi, M, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uchiyama, M1
Iwafuchi, M1
Yagi, M1
Iinuma, Y1
Kanada, S1
Ohtaki, M1
Homma, S1

Other Studies

1 other study available for trimebutine and Short Bowel Syndrome

ArticleYear
Effects of trimebutine on intestinal motility after massive small bowel resection.
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2000, Volume: 36, Issue:4

    Topics: Anastomosis, Surgical; Animals; Disease Models, Animal; Dogs; Duodenum; Fasting; Gastrointestinal Ag

2000